Biotechnology green shoots?
With two life science IPOs earlier this month, and seemingly fewer stories of biotechnology firm liquidations, it seems that the […]
With two life science IPOs earlier this month, and seemingly fewer stories of biotechnology firm liquidations, it seems that the […]
This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’
Financial opportunities for early stage biotech companies Read Post »
For all the talk of the numerous biotechnology companies with mere months of cash left and the predictions of looming
Emergent biotechnology companies are very reliant on capital, often having less than two years capital on hand. Like other businesses
On returning from a meeting with a small biotechnology firm in which I serve on the advisory board, I was
Want biotechnology venture capital? Use a shotgun! Read Post »